Zobrazeno 1 - 10
of 18
pro vyhledávání: '"M. A. Estrina"'
Autor:
O. V. Goloschapov, M. A. Estrina, N. E. Ivanova, I. M. Barkhatov, A. D. Kulagin, S. N. Bondarenko, I. S. Moiseev, I. V. Shlyk, Yu. S. Polushin, B. V. Afanasiev
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 13, Iss 5, Pp 50-57 (2018)
Goal: to demonstrate the rare case of transfusion-associated graft-versus-host disease (TA-GvHD) after transfusion of blood components. The cause of TA-GvHD is implantation of donor lymphocytes, contained in blood components, which is related to immu
Externí odkaz:
https://doaj.org/article/9f13bb91e2f04164981feb9f99a4ebd5
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 24, Iss 1, Pp 40-46 (2017)
Relevance. Hematopoietic stem cell transplantation (HSCT) is one of methods to care patients with malignancy, hematologic and hereditary diseases; in most cases, it requires prolonged and massive substitutionary transfusion therapy. Analysis of effec
Externí odkaz:
https://doaj.org/article/7ac15153c7e44fc591cf076e8e02ecda
Autor:
M. A. Kucher, D. E. Pevtcov, M. A. Estrina, N. E. Ivanova, O. A. Makarenko, B. A. Barishev, B. V. Afanasyev
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 23, Iss 4, Pp 61-65 (2016)
The aim of the research is to identify factors influencing the safety and efficacy of the transfusion therapy with hematopoietic stem cell transplantation (HSCT). From January 1 to December 31, 2015, 329 patients with hematologic diseases and maligna
Externí odkaz:
https://doaj.org/article/3f3391f07ccd4abb928849725b7a0acd
Autor:
Ye. I. Darskaya, N. E. Marami-Zonuzi, Yu. S. Osipov, M. A. Estrina, Ye. V. Babenko, V. N. Vavilov, B. V. Afanasiev
Publikováno v:
Онкогематология, Vol 9, Iss 1, Pp 6-10 (2014)
Therapy results of 91 patients with newly diagnosed multiple myeloma who received autologous hematopoietic stem cells transplantation are presented. According to our data, survival depends on the preransplant response and the amount of transplantatio
Externí odkaz:
https://doaj.org/article/506a51d8c0ac4b82b44595573014e641
Autor:
M. A. Kucher, M. A. Estrina, S. N. Bondarenko, N. E. Ivanova, A. L. Alyansky, B. V. Afanasyev
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 22, Iss 1, Pp 57-59 (2015)
Research objective: To assess the impact of AB0 erythrocyte antigens system incompatibility on complications incidence after allogeneic hematopoietic stem cell transplantation (alloHSCT). Patients and methods. The study included 240 patients - recipi
Externí odkaz:
https://doaj.org/article/b9a6cc42f480458a9ecaf3eba45840bc
Autor:
A. Yu. Polushin, Yu. R. Zalyalov, A. N. Gavrilenko, A. A. Tsynchenko, E. I. Lopatina, I. B. Skiba, M. A. Estrina, E. V. Babenko, A. A. Gotovchikov, L. N. Prakhova, A. G. Ilves, N. A. Totolyan, A. D. Kulagin, A .A. Skoromets
Publikováno v:
Russian neurological journal. 27:25-35
Introduction. In 2018–2020, a study was conducted in the Russian Federation on the efficacy and safety of highdose immunosuppressive therapy with autologous hematopoietic stem cell transplantation (HDIT-AHSCT) in multiple sclerosis (MS).The aim of
Autor:
А. D. Kulagin, I. V. Shlyk, M. А. Estrina, O. V. Goloschapov, Sergey N. Bondarenko, Yu. S. Polushin, I. S. Moiseev, N. E. Ivanova, B. V. Аfanasiev, Ildar M. Barkhatov
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 13, Iss 5, Pp 50-57 (2018)
Goal: to demonstrate the rare case of transfusion-associated graft-versus-host disease (TA-GvHD) after transfusion of blood components. The cause of TA-GvHD is implantation of donor lymphocytes, contained in blood components, which is related to immu
Autor:
N B Mikhailova, A L Alianskij, E V Kondakova, U R Zalyalov, E V Babenko, V S Sergeev, M A Estrina, M A Kucher, A D Kulagin, E S Borzenkova, B V Afanasiev
Publikováno v:
Современная онкология, Vol 16, Iss 1, Pp 48-52 (2014)
AutoHSCT is an effective treatment for patients with relapsed and refractory lymphomas, multiple myeloma, some solid tumors. For a successful transplantation it is necessary to obtain an adequate quality and quantity transplant. Due to the heavy pret
Autor:
E. V. Skorobogataya, P. V. Kruglyakov, B. V. Afanasiev, N. V. Kalmykova, D. G. Polintsev, M. A. Estrina, M. A. Berestovoy
Publikováno v:
Bulletin of experimental biology and medicine. 151(4)
We studied the effect of platelet lysates from different donors on fibroblast growth in culture. In most samples (40 of 50), the growth-stimulating characteristics were greater than in 10% FCS, but every ninth sample exhibited low mitogenic activity.
Publikováno v:
Terapevticheskii arkhiv. 82(7)
To evaluate the efficiency of related and unrelated allogeneic bone marrow transplantation (alloBMT) versus immunosuppressive therapy (IST) in patients with aplastic anemia (AA) having no HLA-compatible bone marrow donor.The study covered 61 patients